Replimune Group, Inc.
Industry: Life Sciences ・ $REPL on Nasdaq
Insider Sale
+$56,131
-5.64%
Shares
Shares Volume: 5,207 Shares
Average Share Price: $10.78
INSIDER
Sarchi Christopher
Chief Commercial Officer (Officer)
reported on Nov 20 2024
traded on Nov 18 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 87,045 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $35,240.96 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 10 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $90,083.13 |
| COMPANY PREVIOUS TRADES |